Baxter International Inc.

BAX ·Healthcare, Medical Devices, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $1.97B $1.76B $3.08B $1.62B $2.95B $3.73B $3.34B $1.84B
Accounts Receivable $1.86B $1.68B $1.72B $2.57B $2.63B $2.01B $1.90B $1.84B
Inventory $2.23B $2.05B $1.92B $2.68B $2.45B $1.92B $1.65B $1.67B
Total Current Assets $6.87B $8.85B $9.60B $8.01B $8.87B $8.41B $7.50B $5.96B
Property, Plant & Equipment $2.91B $2.87B $2.87B $4.70B $5.18B $4.72B $4.51B $4.53B
Goodwill $4.93B $5.28B $5.79B $6.45B $9.84B $3.22B $3.03B $3.00B
Intangible Assets (Excl. Goodwill) $4.37B $5.22B $5.92B $6.79B $7.79B $1.67B $1.47B $1.41B
Total Assets $20.06B $25.78B $28.28B $28.29B $33.52B $20.02B $18.19B $15.72B
Liabilities
Accounts Payable $999.0M $968.0M $881.0M $1.11B $1.25B $1.04B $892.0M $998.0M
Total Current Liabilities $2.97B $6.51B $6.50B $4.75B $4.24B $3.33B $3.23B $2.81B
Long-Term Debt $9.44B $13.18B $13.86B $16.70B $17.75B $6.23B
Total Liabilities $13.95B $18.76B $19.81B $22.39B $24.40B $11.29B $10.28B $7.85B
Stockholders' Equity
Retained Earnings $13.71B $14.93B $16.11B $14.05B $17.07B $16.33B $15.72B $15.08B
Total Stockholders' Equity $6.13B $6.96B $8.40B $5.83B $9.08B $8.69B $7.88B $7.84B
← Newer Page 1 of 3 Older →